SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122402
Filing Date
2024-11-06
Accepted
2024-11-06 16:41:16
Documents
73
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nuvb-20240930.htm   iXBRL 10-Q 2733274
2 EX-31.1 nuvb-ex31_1.htm EX-31.1 16643
3 EX-31.2 nuvb-ex31_2.htm EX-31.2 16733
4 EX-32.1 nuvb-ex32_1.htm EX-32.1 8527
5 EX-32.2 nuvb-ex32_2.htm EX-32.2 7493
  Complete submission text file 0000950170-24-122402.txt   10157538

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nuvb-20240930.xsd EX-101.SCH 1220956
75 EXTRACTED XBRL INSTANCE DOCUMENT nuvb-20240930_htm.xml XML 1944988
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39351 | Film No.: 241431722
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)